|Articles|June 1, 2022
Meeting Regulatory Needs in the Characterization of Lipid Nanoparticles (LNPs) for RNA Delivery via FFF-MALS
Author(s)Wyatt
The white paper discusses a validated FFF-MALS method in line with technical specification ISO/TS 21362 for the analysis of lipid-based nanoparticles (LNPs).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
3
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
4
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
5